The ACR is pleased to welcome the newest members of the ACR board of directors and ARHP executive committee. These new members were confirmed in November during the 2011 ACR/ARHP Annual Scientific Meeting. Over the next two issues of “From the College,” you will be introduced to these new members and learn what they want to gain from their experience as new board and executive committee members.
Incoming ACR Volunteers
William F. Harvey, MD, MSc
William F. Harvey, MD, MSc, is assistant professor of medicine at Tufts Medical Center in Boston. Dr. Harvey has previously served as the fellow liaison for the ACR Government Affairs Committee and Committee on Workforce and Training, and as a member of the fellow subcommittee of the Committee on Workforce and Training. After completing his fellowship, Dr. Harvey served as a member of the Government Affairs Committee. In 2008, he won the ACR Distinguished Fellow Award.
“As the ‘Young Board Member‘ designee, I look forward to representing a new generation of rheumatologists and helping the board of directors keep an eye toward the future while serving the current membership. I look forward to learning more about the needs of our diverse membership,” says Dr. Harvey.
Dr. Holers
V. Michael Holers, MD, is the head of the division of rheumatology and professor of medicine, immunology, and rheumatology at the University of Colorado School of Medicine in Denver. Dr. Holers has been teaching at the University of Colorado School of Medicine since 1993. He has received many awards, including the 2008 ACR Distinguished Basic Investigator Award and REF Within Our Reach: Finding a Cure for Rheumatoid Arthritis research grants.
Dr. Holers says that as an ACR board member, he “would like to advance the goals of the ACR in a period of time that is increasingly challenging with regard to the research, clinical care, and educational missions of its members. We need to work hard to create new opportunities on all fronts for our members in order to maintain our leadership position in an ever-changing professional environment.”
Dr. von Scheven
Emily von Scheven, MD, MAS, is division chief of pediatric rheumatology, professor of clinical pediatrics, and program director of pediatric rheumatology fellowship training at the University of California San Francisco. She is also the co-director of resident research training for the Clinical and Translational Science Institute at the University of California, San Francisco, and elected chair of the lupus subcommittee with the Childhood Arthritis & Rheumatology Research Alliance (CARRA).
As an educator, clinician, and researcher, Dr. von Scheven says, “I feel privileged to be invited to serve on the board of directors of the ACR. The breadth and depth of the organization’s initiatives are admirable, and as a member of the board I hope to learn more about these programs. I look forward to bringing my expertise and experience as a pediatric rheumatologist, clinician, and clinical investigator to the development of the next phase of the organization’s growth.”
Incoming ARHP Volunteers
Lori Cyr
Lori Cyr is the practice coordinator for occupational therapy for the Arthritis and Neuromusculoskeletal Programs at Vancouver Coastal Health, in Vancouver, British Columbia. She is also clinical assistant professor with the University of British Columbia’s department of occupational science and occupational therapy.
A proud Canadian who has been an ARHP member since 1992, she is always happy to share a Canuck perspective. “I am honored to be joining the executive committee this year, having thoroughly enjoyed both the work and the people I have met through volunteering with ARHP,” says Cyr. “I am so impressed with the range and responsiveness of the association’s educational offerings to members and am happy to be back. I’m looking forward to being stimulated and challenged—and rewarded—by the work of this group.”
Dr. Schlenk
Elizabeth A. Schlenk, PhD, RN, is associate professor of nursing at the University of Pittsburgh, where she teaches and conducts research. Her research program is focused on adherence to physical activity regimens in older adults with comorbid chronic disorders. She has a particular interest in osteoarthritis of the knee, which is a barrier to physical activity. She currently has a grant funded by the NIH to investigate an intervention to promote physical activity in older adults with osteoarthritis of the knee and comorbid hypertension. She teaches graduate courses in research and chairs PhD dissertation committees and DNP capstone committees. She has been an active member of ARHP since 1998, most recently serving as the ARHP liaison to the ACR REF Scientific Advisory Council.
“The ARHP is a dynamic interdisciplinary professional organization that provides multiple opportunities for learning and networking,” says Dr. Schlenk. “ARHP members are committed to improving the care and treatment of persons with rheumatic diseases through practice and research. I look forward to serving on the ARHP executive committee as the member-at-large, finance and liaison to the ACR Finance Committee, gaining insight into current and upcoming initiatives of the ACR and ARHP.”
Dr. McLean
Robert R. McLean, DSc, MPH, is a musculoskeletal disease epidemiologist at the Hebrew SeniorLife Institute for Aging Research and Harvard Medical School in Boston. Dr. McLean has been an active participant in the ARHP research community for the past six years, and has presented research methodology workshops at the ACR/ARHP Annual Scientific Meeting for each of those years. As a member of the ARHP Research Committee since 2008, he has helped develop web-based tools for rheumatology researchers and served as chair of the Clinical Care in the Rheumatic Disease Task Force. For 2012, Dr. McLean will join the ARHP executive committee as chair of the ARHP Research Subcommittee.
“Health professionals play an important role in research, which is essential for the overall advancement of rheumatology,” says Dr. McLean. “As an early-career investigator myself, I look forward to my tenure on the ARHP Executive Committee as an opportunity to promote the future of rheumatology research by helping to foster the next generations of health professional researchers.”